Q: Hi, could I please have your opinion on the long end of the yield curve. The consensus seems to be that economic growth is starting to slow, inflation is increasing but may moderate in the second half but remain sticky and that the Fed may make a policy mistake by over tightening. To date the yield curve has steepened, short and long yields have increased, shorts more than longs. How might you see this playing out going forward. Do you think the long end of the curve presents an opportunity at this point? I am considering long perpetual preferreds which have also corrected but offer more generous tax favoured income (around 5%) than long bonds? Many thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello, Recently I had watched a few YouTube videos on Ray Dalio’s new book called the New World Order. I know there is always something to worry about, but, is this something an investor should worry about in the next decade to come ? Basically, the book is about how a new reserve currency will replace the US dollar as the reserve currency. Have you guys spent any time thinking about this as an Canadian investor or what the implications might mean if he is correct ?
Q: If I purchase GoEasy shares today (March 22 2022) will I receive the next dividend? Is the Ex Dividend date March 23, meaning if purchased on March 23 or later I will not receive the next dividend?
Thank you
Thank you
- iShares 1-5 Year Laddered Corporate Bond Index ETF (CBO)
- iShares Core Canadian Short Term Bond Index ETF (XSB)
- iShares Floating Rate Index ETF (XFR)
Q: What would your bond ETF pick be for a 2 year holding period? I have been using XSB and CLF.
- iShares Core Canadian Short Term Bond Index ETF (XSB)
- Vanguard Real Estate Index Fund ETF (VNQ)
- iShares TIPS Bond ETF (TIP)
- Vanguard Energy ETF (VDE)
- The Energy Select Sector SPDR Fund (XLE)
- iShares 0-5 Year TIPS Bond ETF (STIP)
- Invesco DB Commodity Index Tracking Fund (DBC)
Q: According to a G&M article on treat of stagflation, XSB is not a good choice of invest re 40-60 portfolio.
Assuming you agree with this article what would be your top 3 or 4 investment to replace XSB ?
Assuming you agree with this article what would be your top 3 or 4 investment to replace XSB ?
Q: I would like to add 5 or 6 Canadian companies to my portfolio that pay a decent dividend (3%+) and distribute monthly. I'm hoping that you can suggest some companies that fit the bill and you respect for their high quality, leadership and ability to whether the noise created by events such as we are currently experiecing. Thanks in advance for you continued respected advice.
Q: I own Dollarama shares.
If China in sanctioned by the West for supporting Russia would this leave companies like Dollarama vulnerable, as they source lots of Chinese products for their stores?
Thanks
Kim
If China in sanctioned by the West for supporting Russia would this leave companies like Dollarama vulnerable, as they source lots of Chinese products for their stores?
Thanks
Kim
Q: What is your view on Verisk (VRSK)
Q: Could you give me your opinion on the 2 stocks mentioned above. If picking one of the two, which would you prefer?
Thanks.
Thanks.
Q: Do you think Mr. Buffett would ever try to buy ENB?
Q: Good morning 5i
I am wavering between these two. I already own some abbivie. But I hesitate because it has shot up recently. I know you favour it. But I have seen several people lately, today Brian Acre, leaning towards bmy. Here is the reasoning of one such person:
The company has a strong pipeline of new drugs, but also a lot of patent expirations for its big existing drugs coming up, which means the company has to effectively rotate its portfolio of revenue-producing drugs in the coming years. To offset that risk, it is priced very cheaply, with a single-digit price/earnings ratio and a solid dividend yield. I think the current price offers a good accumulation zone.
I am wondering about your different approaches. Would it be that you favour growth more and they are looking for safe income?
Thanks as always
I am wavering between these two. I already own some abbivie. But I hesitate because it has shot up recently. I know you favour it. But I have seen several people lately, today Brian Acre, leaning towards bmy. Here is the reasoning of one such person:
The company has a strong pipeline of new drugs, but also a lot of patent expirations for its big existing drugs coming up, which means the company has to effectively rotate its portfolio of revenue-producing drugs in the coming years. To offset that risk, it is priced very cheaply, with a single-digit price/earnings ratio and a solid dividend yield. I think the current price offers a good accumulation zone.
I am wondering about your different approaches. Would it be that you favour growth more and they are looking for safe income?
Thanks as always
Q: I was wondering if you could provide any commentary on the newly spun-out company, ZImVie (formerly from Zimmer Biomet). I am familiar with their dental products - they are quite good, and focus primarily on the implant space (including implant fixtures, prosthetic components for tooth replacement and bone regeneration materials), rather than a more diversified product line throughout the dental space. I have spoken to a representative from the company, and my limited understanding is that it seems likelier that they plan to stay focused in this segment of dental health for the foreseeable future.
My question would be as follows: given the limited amount of time they have existed as a stand-alone company, can enough be gleaned from what is publicly available to make an informed decision regarding their longer-term prospects? At this point, I only have the worm’s-eye view (I use their products and like them, as well as their clinical support system), and I could really use a bird’s-eye vantage point. Thanks so much, and I look forward to reading you comments!
My question would be as follows: given the limited amount of time they have existed as a stand-alone company, can enough be gleaned from what is publicly available to make an informed decision regarding their longer-term prospects? At this point, I only have the worm’s-eye view (I use their products and like them, as well as their clinical support system), and I could really use a bird’s-eye vantage point. Thanks so much, and I look forward to reading you comments!
Q: hello 5i:
comparing these two companies, which do you like better and why?
thanks
Paul L
comparing these two companies, which do you like better and why?
thanks
Paul L
Q: Considering I want safety, then income, then growth…this looks a time to buy more of ISV. Those quarterly earnings appear to have impressed nobody but me! Am I missing something? Is it just the market has different priorities…ie growth first.
Q: Down big time. What’s happening?
Sheldon
Sheldon
- Costco Wholesale Corporation (COST)
- AbbVie Inc. (ABBV)
- Home Depot Inc. (The) (HD)
- JPMorgan Chase & Co. (JPM)
- McDonald's Corporation (MCD)
- Realty Income Corporation (O)
- Prologis Inc. (PLD)
- Public Storage (PSA)
Q: Good morning. I am looking to add a new US dividend growth stock to my RRSP. My top contenders are Costco, Home Depot and McDonald's. What would be your top choice today? Do you have any better suggestions (stocks or REIT's)? Thank you.
Kim
Kim
- AbbVie Inc. (ABBV)
- Home Depot Inc. (The) (HD)
- JPMorgan Chase & Co. (JPM)
- 3M Company (MMM)
- Realty Income Corporation (O)
- Verizon Communications Inc. (VZ)
Q: Good Morning. I am selling off some of my more volatile US tech stocks in my RRIF and am looking to redeploy the proceeds into US stable Dividend payors. Can you please suggest 5 or 6 US Dividend stocks ( other than US Tech) to look at? Thanks
Q: I'm a bit confused when I look at your assessment when you refer to ATD being a defensive position whereby it's considered a consumer cyclical in your classification. I understand that it could be an hybrid. How do I deal with my position weighting as my cons staples is underweight VS overweight in my cyclical by the same amount...
Thanks for your welcome enlightenment.
Yves
Thanks for your welcome enlightenment.
Yves
Q: Upon reading your recent report about its business model I am wondering how closely it competes with NAS nationwide appraisal service a private coy out of Markham Ontario and seemingly larger?
Q: Hi, I have held this stock for a few years. Would you continue to hold it can u suggest an alternative. Thanks Clare